Carregant...
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
The interaction between the bone marrow microenvironment and plasma cells plays an essential role in multiple myeloma progression and drug resistance. The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) pathway in vascular endothelial cells activates and promotes angiogenesis. Moreov...
Guardat en:
| Publicat a: | J Clin Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7355441/ https://ncbi.nlm.nih.gov/pubmed/32517267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061765 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|